This is a device, not a treatment.
Its selling price is maybe too low.
In the area of head problems, I prefer and hold the drug company with a possible treatment for Idiopathic Intracranial Hypertension and maybe also Traumatic Brain Injury.
It has a repurposed drug and its EV is low for a P3 trial.
Hiq will come to the rescue ,as Afl facing a $60m lawsuit for concussion, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.734M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 111650 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 6000 | 1 |
View Market Depth
| Last trade - 16.35pm 29/07/2025 (20 minute delay) ? |
| HIQ (ASX) Chart |
Day chart unavailable